RECRUITING

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall purpose of this pilot study is to examine the feasibility, acceptability, and tolerability of light and moderate intensity exercise in adults with MGeffect of light vs. moderate intensity exercise on health outcomes. Participants will be enrolled into the NeuroWell exercise program, which is geared toward individuals with neurological disorders or injuries and led by Certified Exercise Physiologists (CEPs) at the HealthPartners Neuroscience Center. A total of 20 people with MG will be enrolled in this study and participate in a small group exercise program 3 times a week for 12 weeks. Participants will be randomized into two exercise groups: 1) Light intensity or 2) Moderate intensity. We hypothesize that light and moderate intensity exercise will be feasible, acceptable, and tolerable in adults with MG and that individuals in the light intensity exercise group will be able to achieve the same improvement in health outcomes as the moderate intensity group.

Official Title

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Quick Facts

Study Start:2024-09-16
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06491238

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to provide and provision of signed and dated informed consent form.
  2. * Age 18-80
  3. * Diagnosis of generalized MG.
  4. * On a stable MG prescription medication regimen for the last 3 months.
  1. * Non-English speaking
  2. * Regular exercise participation within the month prior to study enrollment or any outside exercise participation during the study intervention period.
  3. * Significant cognitive impairment of any etiology that would impact study participation.
  4. * History of heart failure, chronic lung disease, angina or any other condition that causes unreasonable shortness of breath on exertion.
  5. * History of any serious neurological, psychiatric, or substance use disorders that would impact study participation.
  6. * Women who are currently pregnant or planning to become pregnant during the study.
  7. * Any other medical conditions that could affect their ability to participate in exercise for the study duration (as determined by study investigators).
  8. * Active participation or past participation ≤3 months in any other interventional research study.
  9. * Unwilling to participate in all study related activities.

Contacts and Locations

Study Contact

Clinical Trials Coordinator
CONTACT
651-495-6363
ClinicalTrials@HealthPartners.com

Study Locations (Sites)

HealthPartners Neuroscience Center
Saint Paul, Minnesota, 55130
United States

Collaborators and Investigators

Sponsor: HealthPartners Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-16
Study Completion Date2025-07

Study Record Updates

Study Start Date2024-09-16
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Myasthenia Gravis